Validation that the CF33 platform is working just like it did on...

Validation that the CF33 platform is working just like it did on rodents.

Well that's my take on this licenses allogeneic Car T cell therapy.

There is a bit involved in this deal, not just the money and shares.

Precision is happy to accept payment in the form of convertible.

notes, that shows plenty of confidence in what IMU are offering

in the form of IP it has.

Yes, the cap raise and dilution is a downer, and no one really seen!

this coming, especially not me. At first I was not shore about the hole

thing, but with further digging I'm absolutely thrilled with this deal.

The strategy here is brilliant. Getting a Car T that can now go strait into

a registrational trail. IMU can partner with other big pharma Car T's

and also have their own Car T to go on with, this could be game changing

when you think about it. We should have all seen something like this

coming, there were enough hints a the latest presentations'.

Another plus is that the Car T is allogenic, hence my opinion it could

be a big game changer, it all points to an off the shelf cancer treatment

that will be a lot cheaper than anything else out there.

This now becomes a complete package for a company take over or

licencing to a major big pharma. Also, and of course is the elephant

in the room, the manufacturing facility. 50 employes already to go

and the size of it indicates there is plenty of confidence with in the

IMU team., the factory has already got FDA approval,

they know what the data is showing and they know what

they have. Why else would you do a deal like this, they are sure now

because its working in humans just like they were anticipating.

Big Pharma always seem to hold the cards, but when IMU present to the

world what they really have, it will be IMU holding the cards in my

opinion.

I can only go back to the last time I had a chat with Dr Yuman Fong a

few mouths back, he wanted to tell me and my friend so much more

but he could not for obvious reasons, but he did say all in good time

we could be looking at a cure for cancer and wouldn't that be

just marvelous for all.

There is nothing that I have said that others have not already, but

for me and my investment in IMU, I'm very, very happy with where

they are heading and this latest development gives me more confidence

that we are on a big winner .

This is just my opinion and not financial advice.